Advances in generative AI have taken the tech world by storm. Biotech buyers are making an enormous wager that related computational strategies might revolutionize drug discovery. On Tuesday, ARCH Enterprise Companions and Foresite Labs, an affiliate of Foresite Capital, introduced that they incubated Xaira Therapeutics and funded the AI biotech with $1 billion. Different buyers […]
© 2024 TechCrunch. All rights reserved. For private use solely.